Back
 JBM  Vol.4 No.10 , October 2016
Gastric Atrophy, Intestinal Metaplasia in Helicobacter pylori Gastritis: Prevalence and Predictors Factors
Abstract: Gastric atrophy and intestinal metaplasia represent the most important premalignant lesions in gastric carcinogenesis. The severity of gastric mucosal inflammation depends on the bacterium Helicobacter pylori (HP), on the host and on environmental factors. The aim of our study is to determine the prevalence and factors associated with Gastric atrophy and intestinal metaplasia in patients infected with Helicobacter pylori. Methods: This is a prospective study over a period of 4 years (May 2009 - January 2015) conducted in the service of Hepatology and Gastroenterology in hospital university Hassan II of Fez in collaboration with microbiology and molecular biology laboratory and epidemiology service of Faculty of Medicine and Pharmacy Fes. We included in our study all patients aged over 15 years, having ulcerative dyspepsia, peptic ulcer disease, gastritis or esophagitis. Results: During the study period, 1190 patients were included of which 70% had HP infection (N = 833). The average age was 48.21 years [16 - 99 years], sex ratio M/F was 1, 11. 60% of patients were older than 45 years. Chronic smoking was found in 12% of patients. Gastric atrophy was observed in 84% (N = 699) of patients infected with HP. Gastric atrophy was localized in 70% in the antrum and 30% in the fundus and 24% in both. The activity of gastritis (p = 0.0001) and the density of the HP (p = 0.005) were factors associated with atrophy. Intestinal metaplasia was observed in 13.5% of patients (N = 112). The density of HP (p = 0.037) and severe atrophy (p = 0.001) were factors associated with metaplasia. Other factors studied: age, sex, smoking, CagA+ genotype were not associated with either gastric atrophy or intestinal metaplasia. Conclusion: In our study, the prevalence of atrophic gastritis and intestinal metaplasia in patients infected with Helicobacter pylori was 84% and 13.5% respectively, which was a high prevalence. The activity of gastritis, and density of HP were factors associated with atrophy. The density of HP and severe atrophy were factors associated with metaplasia.
Cite this paper: Adadi, S. , Bennani, B. , Elabkari, M. , Ibrahimi, A. , Alaoui, S. , Elkhadir, M. , Harmouch, T. , Mahmoud, M. , Nejjari, C. and Benajah, D. (2016) Gastric Atrophy, Intestinal Metaplasia in Helicobacter pylori Gastritis: Prevalence and Predictors Factors. Journal of Biosciences and Medicines, 4, 43-49. doi: 10.4236/jbm.2016.410005.
References

[1]   Correa, P. (1992) Human Gastric Carcinogenesis: A Multistep and Multifactorial Process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Research, 52, 6735-6740.

[2]   Correa, P., Cuello, C., Duque, E., et al. (1976) Gastric Cancer in Columbia. III. Natural History of Precursor Lesions. Journal of the National Cancer Institute, 57, 1027-1035.

[3]   Correa, P. (1988) A Human Model of Gastric Carcino Genesis. Cancer Research, 48, 1319-1326.

[4]   Delchier, J.-C. (2004) Les lésions précancéreuses gastriques: Quelle prévention: Gastro-entérol. Clin Bio.

[5]   You, W.C., Zhang, L., Gail, M.H., Li, J.Y., Chang, Y.S., Blot, W.J., Zhao, C.L., Liu, W.D., Li, H.Q., Ma, J.L., Hu, Y.R., Bravo, J.C., Correa, P., Xu, G.W. and Fraumeni Jr., J.F. (1998) Precancerous Lesions in Two Counties of China with Contrasting Gastric Cancer Risk. International Journal of Epidemiology, 27, 945-948.
http://dx.doi.org/10.1093/ije/27.6.945

[6]   Kawaguchi, H., Haruma, K., Komoto, K., Yoshihara, M., Sumii, K. and Kajiyama, G. Helicobacter pylori Infection Is the Major Risk.

[7]   Uemura, N., Okamoto, S. and Yamamoto, S. Helicobacter pylori Infection and the Development of Gastric Cancer. New England Journal of Medicine, 345, 784-789.
http://dx.doi.org/10.1056/NEJMoa001999

[8]   Uemura, N., Mukai, T. and Okamoto, S. (1997) Effect of Helicobacter pylori Eradication on Subsequent Development of Cancer after Endoscopic Resection of Early Gastric Cancer. Cancer Epidemiology, Biomarkers & Prevention, 6, 639-642.

[9]   Leung, W.K., Lin, S.-R., Ching, J.Y.L., To, K.-F., Ng, E.K.W., Chan, F.K.L., Lau, J.Y.W. and Sung, J.J.Y. (2001) Prospects for Intervention in Gastric Carcinogenesis: Reversibility of Gastric Atrophy and Intestinal Metaplasia. Gut, 49, 2-4.
http://dx.doi.org/10.1136/gut.49.1.2

[10]   Walker, M. (2003) Is Intestinal Metaplasia of the Stomach Reversible? Gut, 52, 1-4.
http://dx.doi.org/10.1136/gut.52.1.1

[11]   Ito, M., Haruma, K., Kamada, T., Mihara, M., Kim, S., Kitadai, Y., Sumii, M., Tanaka, S., Yoshihara, M. and Chayama, K. (2002) Helicobacter pylori Eradication Therapy Improves Atrophic Gastritis and Intestinal Metaplasia: A 5-Year Prospective Study of Patients with Atrophic Gastritis Aliment. Pharmacology & Therapeutics, 16, 1449-1456.
http://dx.doi.org/10.1046/j.1365-2036.2002.01311.x

[12]   Leung, W.K., Lin, S.-R., Ching, J.Y.L., To, K.-F., Ng, E.K.W., Chan, F.K.L., Lau, J.Y.W. and Sung, J.J.Y. (2004) Factors Predicting Progression of Gastric Intestinal Metaplasia: Results of a Randomised Trial on Helicobacter pylori Eradication. Gut, 53, 1244-1249.
http://dx.doi.org/10.1136/gut.2003.034629

[13]   Sung, J.J.Y., Lin, S.R. and Ching, J.Y.L. (2000) Atrophy and Intestinal Metaplasia One Year after Cure of H. pylori Infection: A Prospective Randomized Study. Gastroenterology, 119, 7-14.
http://dx.doi.org/10.1053/gast.2000.8550

[14]   Ohkusa, T., Fujiki, K. and Takashimizu, I. (2001) Improvement of Atrophic Gastritis and Intestinal Metaplasia in Patients in Whom Helicobacter pylori Was Eradicated. Annals of Internal Medicine, 134, 380-386.
http://dx.doi.org/10.7326/0003-4819-134-5-200103060-00010

[15]   Nakamura, M., Haruma, K. and Kamada, T. (2002) Cigarette Smoking Promotes Atrophic Gastritis in Helicobacter pylori-Positive Subjects. Digestive Diseases and Sciences, 47, 675-681.
http://dx.doi.org/10.1023/A:1017901110580

[16]   Hackelsberger, A., Gunther, T. and Schultze, V. (1999) Role of Aging in the Expression of Helicobacter pylori Gastritis in the Antrum, Corpus, and Cardia. Scandinavian Journal of Gastroenterology, 34, 138-143.
http://dx.doi.org/10.1080/00365529950172989

[17]   Schubert, T.T., Schubert, A.B. and Ma, C.K. (1992) Symptoms, Gastritis, and Helicobacter pylori in Patients Referred for Endoscopy. Gastrointestinal Endoscopy, 38, 357-360.
http://dx.doi.org/10.1016/S0016-5107(92)70432-5

[18]   Chen, X.-Y., van der Hulst, R.W.M. and Shi, Y. (2001) Comparison of Precancerous Conditions: Atrophy and Intestinal Metaplasia in Helicobacter pylori Gastritis among Chinese and Dutch Patients. Journal of Clinical Pathology, 54, 367-370.
http://dx.doi.org/10.1136/jcp.54.5.367

[19]   The Eurohepygast Study Group (2002) Risk Factors for Atrophic Chronic Gastritis in a European Population: Results of the Eurohepygast Study. Gut, 50, 779-785.
http://dx.doi.org/10.1136/gut.50.6.779

[20]   Ren, Z., Pang, G., Batey, R. and Routley, D. (2000) Non-Urease Producing Helicobacter pylori in Chronic Gastritis. Australian & New Zealand Journal of Medicine, 30, 578-584.
http://dx.doi.org/10.1111/j.1445-5994.2000.tb00859.x

 
 
Top